News and media

A world-first therapy for helping smokers quit that uses a nicotine-filled inhaler in combination with a nicotine patch has doubled quit rates compared to smokers using a nicotine patch only.

The government is seeking public input on the development of what will be New Zealand’s first health research strategy.

The government has today announced that the Health Research Council of New Zealand (HRC) will receive a significant new investment of $97 million over the next four years.

A new HRC emerging researcher study, one of 11 announced today, aims to manufacture human corneal replacements from proteins found in fish eye lenses.

A new trial funded by a HRC feasibility study grant will collect real-time data from e-cigarette users using a novel ‘smart’ e-cigarette.

A Christchurch researcher is doing New Zealand's first study of vitamin C's potential as a treatment for intensive care patients with sepsis.

Distinguished Professor Richard Faull and Dr Ilva Rupenthal have received the first HRC awards for an outstanding contribution to health research excellence.

A Christchurch study has found that abnormalities detected in the brains of some of those born very prematurely persist into late childhood.